nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A2—Vinblastine—lung cancer	0.133	0.263	CbGbCtD
Famotidine—SLC22A2—Cisplatin—lung cancer	0.122	0.242	CbGbCtD
Famotidine—CYP2C19—Gefitinib—lung cancer	0.0923	0.183	CbGbCtD
Famotidine—CYP2C19—Teniposide—lung cancer	0.0895	0.178	CbGbCtD
Famotidine—SLC22A8—Methotrexate—lung cancer	0.0678	0.134	CbGbCtD
Famotidine—Infection—Paclitaxel—lung cancer	0.000273	0.000673	CcSEcCtD
Famotidine—Erectile dysfunction—Methotrexate—lung cancer	0.000272	0.000671	CcSEcCtD
Famotidine—Dry skin—Doxorubicin—lung cancer	0.000271	0.000669	CcSEcCtD
Famotidine—Feeling abnormal—Gemcitabine—lung cancer	0.000271	0.000667	CcSEcCtD
Famotidine—Shock—Paclitaxel—lung cancer	0.000271	0.000667	CcSEcCtD
Famotidine—Dizziness—Vinorelbine—lung cancer	0.00027	0.000666	CcSEcCtD
Famotidine—Photosensitivity reaction—Methotrexate—lung cancer	0.00027	0.000665	CcSEcCtD
Famotidine—Thrombocytopenia—Paclitaxel—lung cancer	0.000269	0.000664	CcSEcCtD
Famotidine—Anorexia—Etoposide—lung cancer	0.000267	0.000659	CcSEcCtD
Famotidine—Body temperature increased—Irinotecan—lung cancer	0.000267	0.000657	CcSEcCtD
Famotidine—Abdominal pain—Irinotecan—lung cancer	0.000267	0.000657	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000266	0.000657	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000266	0.000657	CcSEcCtD
Famotidine—Decreased appetite—Cisplatin—lung cancer	0.000266	0.000656	CcSEcCtD
Famotidine—Anaemia—Docetaxel—lung cancer	0.000264	0.000651	CcSEcCtD
Famotidine—Depression—Methotrexate—lung cancer	0.000263	0.000647	CcSEcCtD
Famotidine—Anorexia—Paclitaxel—lung cancer	0.000262	0.000646	CcSEcCtD
Famotidine—Pain—Cisplatin—lung cancer	0.000262	0.000645	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000261	0.000644	CcSEcCtD
Famotidine—Vomiting—Vinorelbine—lung cancer	0.00026	0.000641	CcSEcCtD
Famotidine—Body temperature increased—Gemcitabine—lung cancer	0.00026	0.00064	CcSEcCtD
Famotidine—Rash—Vinorelbine—lung cancer	0.000258	0.000635	CcSEcCtD
Famotidine—Dermatitis—Vinorelbine—lung cancer	0.000257	0.000635	CcSEcCtD
Famotidine—Headache—Vinorelbine—lung cancer	0.000256	0.000631	CcSEcCtD
Famotidine—Syncope—Docetaxel—lung cancer	0.000256	0.000631	CcSEcCtD
Famotidine—Influenza—Doxorubicin—lung cancer	0.000256	0.00063	CcSEcCtD
Famotidine—Leukopenia—Docetaxel—lung cancer	0.000256	0.00063	CcSEcCtD
Famotidine—Palpitations—Docetaxel—lung cancer	0.000252	0.000622	CcSEcCtD
Famotidine—Feeling abnormal—Cisplatin—lung cancer	0.000252	0.000622	CcSEcCtD
Famotidine—Paraesthesia—Etoposide—lung cancer	0.000252	0.000621	CcSEcCtD
Famotidine—Haematuria—Methotrexate—lung cancer	0.000251	0.000619	CcSEcCtD
Famotidine—Loss of consciousness—Docetaxel—lung cancer	0.000251	0.000619	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00025	0.000617	CcSEcCtD
Famotidine—Somnolence—Etoposide—lung cancer	0.000249	0.000615	CcSEcCtD
Famotidine—Cough—Docetaxel—lung cancer	0.000249	0.000614	CcSEcCtD
Famotidine—Insomnia—Paclitaxel—lung cancer	0.000249	0.000613	CcSEcCtD
Famotidine—Hypersensitivity—Irinotecan—lung cancer	0.000248	0.000612	CcSEcCtD
Famotidine—Convulsion—Docetaxel—lung cancer	0.000247	0.00061	CcSEcCtD
Famotidine—Paraesthesia—Paclitaxel—lung cancer	0.000247	0.000609	CcSEcCtD
Famotidine—Bronchitis—Doxorubicin—lung cancer	0.000246	0.000606	CcSEcCtD
Famotidine—Agranulocytosis—Methotrexate—lung cancer	0.000246	0.000606	CcSEcCtD
Famotidine—Somnolence—Paclitaxel—lung cancer	0.000244	0.000603	CcSEcCtD
Famotidine—Decreased appetite—Etoposide—lung cancer	0.000244	0.000601	CcSEcCtD
Famotidine—Chest pain—Docetaxel—lung cancer	0.000243	0.000599	CcSEcCtD
Famotidine—Arthralgia—Docetaxel—lung cancer	0.000243	0.000599	CcSEcCtD
Famotidine—Myalgia—Docetaxel—lung cancer	0.000243	0.000599	CcSEcCtD
Famotidine—Pancytopenia—Doxorubicin—lung cancer	0.000243	0.000599	CcSEcCtD
Famotidine—Nausea—Vinorelbine—lung cancer	0.000243	0.000599	CcSEcCtD
Famotidine—Dyspepsia—Paclitaxel—lung cancer	0.000242	0.000597	CcSEcCtD
Famotidine—Body temperature increased—Cisplatin—lung cancer	0.000242	0.000596	CcSEcCtD
Famotidine—Asthenia—Irinotecan—lung cancer	0.000242	0.000596	CcSEcCtD
Famotidine—Fatigue—Etoposide—lung cancer	0.000242	0.000596	CcSEcCtD
Famotidine—Constipation—Etoposide—lung cancer	0.00024	0.000591	CcSEcCtD
Famotidine—Pain—Etoposide—lung cancer	0.00024	0.000591	CcSEcCtD
Famotidine—Dysuria—Doxorubicin—lung cancer	0.000239	0.00059	CcSEcCtD
Famotidine—Neutropenia—Doxorubicin—lung cancer	0.000239	0.00059	CcSEcCtD
Famotidine—Decreased appetite—Paclitaxel—lung cancer	0.000239	0.000589	CcSEcCtD
Famotidine—Dry mouth—Docetaxel—lung cancer	0.000238	0.000586	CcSEcCtD
Famotidine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000238	0.000586	CcSEcCtD
Famotidine—Fatigue—Paclitaxel—lung cancer	0.000237	0.000584	CcSEcCtD
Famotidine—Hepatitis—Methotrexate—lung cancer	0.000236	0.000583	CcSEcCtD
Famotidine—Pollakiuria—Doxorubicin—lung cancer	0.000236	0.000582	CcSEcCtD
Famotidine—Asthenia—Gemcitabine—lung cancer	0.000236	0.000581	CcSEcCtD
Famotidine—Pain—Paclitaxel—lung cancer	0.000235	0.00058	CcSEcCtD
Famotidine—Constipation—Paclitaxel—lung cancer	0.000235	0.00058	CcSEcCtD
Famotidine—Confusional state—Docetaxel—lung cancer	0.000235	0.000579	CcSEcCtD
Famotidine—Pharyngitis—Methotrexate—lung cancer	0.000235	0.000578	CcSEcCtD
Famotidine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000233	0.000575	CcSEcCtD
Famotidine—Oedema—Docetaxel—lung cancer	0.000233	0.000574	CcSEcCtD
Famotidine—Anaphylactic shock—Docetaxel—lung cancer	0.000233	0.000574	CcSEcCtD
Famotidine—Pruritus—Gemcitabine—lung cancer	0.000232	0.000573	CcSEcCtD
Famotidine—Infection—Docetaxel—lung cancer	0.000232	0.000571	CcSEcCtD
Famotidine—Feeling abnormal—Etoposide—lung cancer	0.000231	0.00057	CcSEcCtD
Famotidine—Diarrhoea—Irinotecan—lung cancer	0.000231	0.000569	CcSEcCtD
Famotidine—Gastrointestinal pain—Etoposide—lung cancer	0.000229	0.000565	CcSEcCtD
Famotidine—Shock—Docetaxel—lung cancer	0.000229	0.000565	CcSEcCtD
Famotidine—Thrombocytopenia—Docetaxel—lung cancer	0.000228	0.000562	CcSEcCtD
Famotidine—Feeling abnormal—Paclitaxel—lung cancer	0.000227	0.000559	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000226	0.000557	CcSEcCtD
Famotidine—Hypersensitivity—Cisplatin—lung cancer	0.000226	0.000556	CcSEcCtD
Famotidine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000225	0.000554	CcSEcCtD
Famotidine—Diarrhoea—Gemcitabine—lung cancer	0.000225	0.000554	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—lung cancer	0.000224	0.000551	CcSEcCtD
Famotidine—Dizziness—Irinotecan—lung cancer	0.000223	0.00055	CcSEcCtD
Famotidine—Urticaria—Etoposide—lung cancer	0.000223	0.000549	CcSEcCtD
Famotidine—Jaundice—Doxorubicin—lung cancer	0.000222	0.000548	CcSEcCtD
Famotidine—Anorexia—Docetaxel—lung cancer	0.000222	0.000548	CcSEcCtD
Famotidine—Abdominal pain—Etoposide—lung cancer	0.000222	0.000546	CcSEcCtD
Famotidine—Body temperature increased—Etoposide—lung cancer	0.000222	0.000546	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—lung cancer	0.00022	0.000543	CcSEcCtD
Famotidine—Asthenia—Cisplatin—lung cancer	0.00022	0.000541	CcSEcCtD
Famotidine—Urticaria—Paclitaxel—lung cancer	0.000218	0.000538	CcSEcCtD
Famotidine—Haematuria—Doxorubicin—lung cancer	0.000217	0.000536	CcSEcCtD
Famotidine—Abdominal pain—Paclitaxel—lung cancer	0.000217	0.000536	CcSEcCtD
Famotidine—Body temperature increased—Paclitaxel—lung cancer	0.000217	0.000536	CcSEcCtD
Famotidine—Vomiting—Irinotecan—lung cancer	0.000214	0.000528	CcSEcCtD
Famotidine—Sinusitis—Doxorubicin—lung cancer	0.000214	0.000527	CcSEcCtD
Famotidine—Agranulocytosis—Doxorubicin—lung cancer	0.000213	0.000525	CcSEcCtD
Famotidine—Rash—Irinotecan—lung cancer	0.000213	0.000524	CcSEcCtD
Famotidine—Dermatitis—Irinotecan—lung cancer	0.000212	0.000523	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000212	0.000523	CcSEcCtD
Famotidine—Headache—Irinotecan—lung cancer	0.000211	0.000521	CcSEcCtD
Famotidine—Insomnia—Docetaxel—lung cancer	0.000211	0.00052	CcSEcCtD
Famotidine—Diarrhoea—Cisplatin—lung cancer	0.000209	0.000516	CcSEcCtD
Famotidine—Paraesthesia—Docetaxel—lung cancer	0.000209	0.000516	CcSEcCtD
Famotidine—Alopecia—Methotrexate—lung cancer	0.000209	0.000515	CcSEcCtD
Famotidine—Vomiting—Gemcitabine—lung cancer	0.000209	0.000515	CcSEcCtD
Famotidine—Bradycardia—Doxorubicin—lung cancer	0.000208	0.000514	CcSEcCtD
Famotidine—Somnolence—Docetaxel—lung cancer	0.000207	0.000511	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—lung cancer	0.000207	0.000511	CcSEcCtD
Famotidine—Rash—Gemcitabine—lung cancer	0.000207	0.00051	CcSEcCtD
Famotidine—Dermatitis—Gemcitabine—lung cancer	0.000207	0.00051	CcSEcCtD
Famotidine—Hypersensitivity—Etoposide—lung cancer	0.000207	0.000509	CcSEcCtD
Famotidine—Headache—Gemcitabine—lung cancer	0.000206	0.000507	CcSEcCtD
Famotidine—Dyspepsia—Docetaxel—lung cancer	0.000205	0.000506	CcSEcCtD
Famotidine—Hepatitis—Doxorubicin—lung cancer	0.000205	0.000505	CcSEcCtD
Famotidine—Pharyngitis—Doxorubicin—lung cancer	0.000203	0.000501	CcSEcCtD
Famotidine—Decreased appetite—Docetaxel—lung cancer	0.000203	0.000499	CcSEcCtD
Famotidine—Hypersensitivity—Paclitaxel—lung cancer	0.000203	0.000499	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—lung cancer	0.000202	0.000497	CcSEcCtD
Famotidine—Asthenia—Etoposide—lung cancer	0.000201	0.000496	CcSEcCtD
Famotidine—Fatigue—Docetaxel—lung cancer	0.000201	0.000495	CcSEcCtD
Famotidine—Nausea—Irinotecan—lung cancer	0.0002	0.000494	CcSEcCtD
Famotidine—Pain—Docetaxel—lung cancer	0.000199	0.000491	CcSEcCtD
Famotidine—Constipation—Docetaxel—lung cancer	0.000199	0.000491	CcSEcCtD
Famotidine—Back pain—Methotrexate—lung cancer	0.000199	0.000491	CcSEcCtD
Famotidine—Pruritus—Etoposide—lung cancer	0.000198	0.000489	CcSEcCtD
Famotidine—Asthenia—Paclitaxel—lung cancer	0.000197	0.000486	CcSEcCtD
Famotidine—Nausea—Gemcitabine—lung cancer	0.000195	0.000481	CcSEcCtD
Famotidine—Vomiting—Cisplatin—lung cancer	0.000195	0.00048	CcSEcCtD
Famotidine—Pruritus—Paclitaxel—lung cancer	0.000195	0.00048	CcSEcCtD
Famotidine—Erythema multiforme—Doxorubicin—lung cancer	0.000194	0.000477	CcSEcCtD
Famotidine—Rash—Cisplatin—lung cancer	0.000193	0.000476	CcSEcCtD
Famotidine—Dermatitis—Cisplatin—lung cancer	0.000193	0.000475	CcSEcCtD
Famotidine—Feeling abnormal—Docetaxel—lung cancer	0.000192	0.000473	CcSEcCtD
Famotidine—Diarrhoea—Etoposide—lung cancer	0.000192	0.000473	CcSEcCtD
Famotidine—Tinnitus—Doxorubicin—lung cancer	0.000191	0.000471	CcSEcCtD
Famotidine—Gastrointestinal pain—Docetaxel—lung cancer	0.000191	0.00047	CcSEcCtD
Famotidine—Anaemia—Methotrexate—lung cancer	0.00019	0.000469	CcSEcCtD
Famotidine—Flushing—Doxorubicin—lung cancer	0.00019	0.000468	CcSEcCtD
Famotidine—Diarrhoea—Paclitaxel—lung cancer	0.000188	0.000464	CcSEcCtD
Famotidine—Dizziness—Etoposide—lung cancer	0.000185	0.000457	CcSEcCtD
Famotidine—Abdominal pain—Docetaxel—lung cancer	0.000184	0.000454	CcSEcCtD
Famotidine—Body temperature increased—Docetaxel—lung cancer	0.000184	0.000454	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—lung cancer	0.000184	0.000454	CcSEcCtD
Famotidine—Arrhythmia—Doxorubicin—lung cancer	0.000183	0.000451	CcSEcCtD
Famotidine—Dizziness—Paclitaxel—lung cancer	0.000182	0.000448	CcSEcCtD
Famotidine—Nausea—Cisplatin—lung cancer	0.000182	0.000448	CcSEcCtD
Famotidine—Alopecia—Doxorubicin—lung cancer	0.000181	0.000446	CcSEcCtD
Famotidine—Cough—Methotrexate—lung cancer	0.00018	0.000443	CcSEcCtD
Famotidine—Mental disorder—Doxorubicin—lung cancer	0.000179	0.000442	CcSEcCtD
Famotidine—Convulsion—Methotrexate—lung cancer	0.000178	0.00044	CcSEcCtD
Famotidine—Vomiting—Etoposide—lung cancer	0.000178	0.00044	CcSEcCtD
Famotidine—Rash—Etoposide—lung cancer	0.000177	0.000436	CcSEcCtD
Famotidine—Dermatitis—Etoposide—lung cancer	0.000177	0.000435	CcSEcCtD
Famotidine—Headache—Etoposide—lung cancer	0.000176	0.000433	CcSEcCtD
Famotidine—Chest pain—Methotrexate—lung cancer	0.000175	0.000432	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—lung cancer	0.000175	0.000432	CcSEcCtD
Famotidine—Myalgia—Methotrexate—lung cancer	0.000175	0.000432	CcSEcCtD
Famotidine—Vomiting—Paclitaxel—lung cancer	0.000175	0.000431	CcSEcCtD
Famotidine—Dysgeusia—Doxorubicin—lung cancer	0.000175	0.00043	CcSEcCtD
Famotidine—Rash—Paclitaxel—lung cancer	0.000173	0.000427	CcSEcCtD
Famotidine—Dermatitis—Paclitaxel—lung cancer	0.000173	0.000427	CcSEcCtD
Famotidine—Back pain—Doxorubicin—lung cancer	0.000172	0.000425	CcSEcCtD
Famotidine—Headache—Paclitaxel—lung cancer	0.000172	0.000425	CcSEcCtD
Famotidine—Hypersensitivity—Docetaxel—lung cancer	0.000172	0.000423	CcSEcCtD
Famotidine—Muscle spasms—Doxorubicin—lung cancer	0.000171	0.000422	CcSEcCtD
Famotidine—Confusional state—Methotrexate—lung cancer	0.000169	0.000417	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—lung cancer	0.000168	0.000414	CcSEcCtD
Famotidine—Asthenia—Docetaxel—lung cancer	0.000167	0.000412	CcSEcCtD
Famotidine—Infection—Methotrexate—lung cancer	0.000167	0.000411	CcSEcCtD
Famotidine—Nausea—Etoposide—lung cancer	0.000167	0.000411	CcSEcCtD
Famotidine—Pruritus—Docetaxel—lung cancer	0.000165	0.000406	CcSEcCtD
Famotidine—Anaemia—Doxorubicin—lung cancer	0.000165	0.000406	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—lung cancer	0.000164	0.000405	CcSEcCtD
Famotidine—Agitation—Doxorubicin—lung cancer	0.000164	0.000404	CcSEcCtD
Famotidine—Nausea—Paclitaxel—lung cancer	0.000163	0.000403	CcSEcCtD
Famotidine—Anorexia—Methotrexate—lung cancer	0.00016	0.000395	CcSEcCtD
Famotidine—Syncope—Doxorubicin—lung cancer	0.00016	0.000394	CcSEcCtD
Famotidine—Leukopenia—Doxorubicin—lung cancer	0.00016	0.000393	CcSEcCtD
Famotidine—Diarrhoea—Docetaxel—lung cancer	0.000159	0.000393	CcSEcCtD
Famotidine—Palpitations—Doxorubicin—lung cancer	0.000157	0.000388	CcSEcCtD
Famotidine—Loss of consciousness—Doxorubicin—lung cancer	0.000157	0.000386	CcSEcCtD
Famotidine—Cough—Doxorubicin—lung cancer	0.000156	0.000383	CcSEcCtD
Famotidine—Convulsion—Doxorubicin—lung cancer	0.000154	0.000381	CcSEcCtD
Famotidine—Dizziness—Docetaxel—lung cancer	0.000154	0.00038	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000153	0.000377	CcSEcCtD
Famotidine—Insomnia—Methotrexate—lung cancer	0.000152	0.000374	CcSEcCtD
Famotidine—Myalgia—Doxorubicin—lung cancer	0.000152	0.000374	CcSEcCtD
Famotidine—Arthralgia—Doxorubicin—lung cancer	0.000152	0.000374	CcSEcCtD
Famotidine—Chest pain—Doxorubicin—lung cancer	0.000152	0.000374	CcSEcCtD
Famotidine—Anxiety—Doxorubicin—lung cancer	0.000151	0.000373	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—lung cancer	0.000151	0.000372	CcSEcCtD
Famotidine—Somnolence—Methotrexate—lung cancer	0.000149	0.000368	CcSEcCtD
Famotidine—Dry mouth—Doxorubicin—lung cancer	0.000148	0.000366	CcSEcCtD
Famotidine—Vomiting—Docetaxel—lung cancer	0.000148	0.000365	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—lung cancer	0.000148	0.000364	CcSEcCtD
Famotidine—Rash—Docetaxel—lung cancer	0.000147	0.000362	CcSEcCtD
Famotidine—Dermatitis—Docetaxel—lung cancer	0.000147	0.000362	CcSEcCtD
Famotidine—Confusional state—Doxorubicin—lung cancer	0.000147	0.000362	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—lung cancer	0.000146	0.00036	CcSEcCtD
Famotidine—Headache—Docetaxel—lung cancer	0.000146	0.00036	CcSEcCtD
Famotidine—Anaphylactic shock—Doxorubicin—lung cancer	0.000145	0.000359	CcSEcCtD
Famotidine—Oedema—Doxorubicin—lung cancer	0.000145	0.000359	CcSEcCtD
Famotidine—Fatigue—Methotrexate—lung cancer	0.000145	0.000357	CcSEcCtD
Famotidine—Infection—Doxorubicin—lung cancer	0.000144	0.000356	CcSEcCtD
Famotidine—Pain—Methotrexate—lung cancer	0.000144	0.000354	CcSEcCtD
Famotidine—Shock—Doxorubicin—lung cancer	0.000143	0.000353	CcSEcCtD
Famotidine—Thrombocytopenia—Doxorubicin—lung cancer	0.000142	0.000351	CcSEcCtD
Famotidine—Anorexia—Doxorubicin—lung cancer	0.000139	0.000342	CcSEcCtD
Famotidine—Nausea—Docetaxel—lung cancer	0.000138	0.000341	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—lung cancer	0.000138	0.000341	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—lung cancer	0.000137	0.000339	CcSEcCtD
Famotidine—Urticaria—Methotrexate—lung cancer	0.000133	0.000329	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—lung cancer	0.000133	0.000327	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—lung cancer	0.000133	0.000327	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000133	0.000327	CcSEcCtD
Famotidine—Insomnia—Doxorubicin—lung cancer	0.000132	0.000324	CcSEcCtD
Famotidine—Paraesthesia—Doxorubicin—lung cancer	0.000131	0.000322	CcSEcCtD
Famotidine—Somnolence—Doxorubicin—lung cancer	0.000129	0.000319	CcSEcCtD
Famotidine—Dyspepsia—Doxorubicin—lung cancer	0.000128	0.000316	CcSEcCtD
Famotidine—Decreased appetite—Doxorubicin—lung cancer	0.000126	0.000312	CcSEcCtD
Famotidine—Fatigue—Doxorubicin—lung cancer	0.000125	0.000309	CcSEcCtD
Famotidine—Constipation—Doxorubicin—lung cancer	0.000124	0.000307	CcSEcCtD
Famotidine—Pain—Doxorubicin—lung cancer	0.000124	0.000307	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—lung cancer	0.000124	0.000305	CcSEcCtD
Famotidine—Asthenia—Methotrexate—lung cancer	0.000121	0.000297	CcSEcCtD
Famotidine—Feeling abnormal—Doxorubicin—lung cancer	0.00012	0.000295	CcSEcCtD
Famotidine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000119	0.000293	CcSEcCtD
Famotidine—Pruritus—Methotrexate—lung cancer	0.000119	0.000293	CcSEcCtD
Famotidine—Urticaria—Doxorubicin—lung cancer	0.000116	0.000285	CcSEcCtD
Famotidine—Abdominal pain—Doxorubicin—lung cancer	0.000115	0.000283	CcSEcCtD
Famotidine—Body temperature increased—Doxorubicin—lung cancer	0.000115	0.000283	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—lung cancer	0.000115	0.000283	CcSEcCtD
Famotidine—Dizziness—Methotrexate—lung cancer	0.000111	0.000274	CcSEcCtD
Famotidine—Hypersensitivity—Doxorubicin—lung cancer	0.000107	0.000264	CcSEcCtD
Famotidine—Vomiting—Methotrexate—lung cancer	0.000107	0.000263	CcSEcCtD
Famotidine—Rash—Methotrexate—lung cancer	0.000106	0.000261	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—lung cancer	0.000106	0.000261	CcSEcCtD
Famotidine—Headache—Methotrexate—lung cancer	0.000105	0.000259	CcSEcCtD
Famotidine—Asthenia—Doxorubicin—lung cancer	0.000104	0.000257	CcSEcCtD
Famotidine—Pruritus—Doxorubicin—lung cancer	0.000103	0.000254	CcSEcCtD
Famotidine—Nausea—Methotrexate—lung cancer	9.98e-05	0.000246	CcSEcCtD
Famotidine—Diarrhoea—Doxorubicin—lung cancer	9.95e-05	0.000245	CcSEcCtD
Famotidine—Dizziness—Doxorubicin—lung cancer	9.62e-05	0.000237	CcSEcCtD
Famotidine—CYP2C19—Biological oxidations—GSTP1—lung cancer	9.4e-05	0.00104	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM8—lung cancer	9.3e-05	0.00103	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCG2—lung cancer	9.3e-05	0.00103	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ADCY1—lung cancer	9.3e-05	0.00103	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTP1—lung cancer	9.27e-05	0.00103	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	9.25e-05	0.00103	CbGpPWpGaD
Famotidine—Vomiting—Doxorubicin—lung cancer	9.25e-05	0.000228	CcSEcCtD
Famotidine—Rash—Doxorubicin—lung cancer	9.17e-05	0.000226	CcSEcCtD
Famotidine—Dermatitis—Doxorubicin—lung cancer	9.16e-05	0.000226	CcSEcCtD
Famotidine—Headache—Doxorubicin—lung cancer	9.11e-05	0.000225	CcSEcCtD
Famotidine—HRH2—GPCR ligand binding—POMC—lung cancer	9.11e-05	0.00101	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—APP—lung cancer	9.04e-05	0.001	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SKI—lung cancer	9.01e-05	0.001	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HSD17B10—lung cancer	8.92e-05	0.000991	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—TF—lung cancer	8.65e-05	0.00096	CbGpPWpGaD
Famotidine—Nausea—Doxorubicin—lung cancer	8.64e-05	0.000213	CcSEcCtD
Famotidine—CYP2C19—Biological oxidations—GSTM1—lung cancer	8.64e-05	0.000959	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	8.61e-05	0.000956	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTM1—lung cancer	8.52e-05	0.000946	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	8.34e-05	0.000926	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CKB—lung cancer	8.29e-05	0.000921	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP1A1—lung cancer	8.19e-05	0.000909	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP1A1—lung cancer	8.08e-05	0.000897	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MDM2—lung cancer	8e-05	0.000888	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—RAF1—lung cancer	7.97e-05	0.000885	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PXN—lung cancer	7.82e-05	0.000869	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM2—lung cancer	7.8e-05	0.000866	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CNDP2—lung cancer	7.8e-05	0.000866	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AVP—lung cancer	7.75e-05	0.00086	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OXTR—lung cancer	7.66e-05	0.000851	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRP—lung cancer	7.66e-05	0.000851	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKR1C1—lung cancer	7.66e-05	0.000851	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTMR3—lung cancer	7.58e-05	0.000842	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PGAM1—lung cancer	7.39e-05	0.000821	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—BRAF—lung cancer	7.31e-05	0.000812	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COL4A3BP—lung cancer	7.2e-05	0.0008	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AZIN2—lung cancer	7.2e-05	0.0008	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GNG11—lung cancer	7.17e-05	0.000796	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—ALB—lung cancer	7.14e-05	0.000793	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2A7—lung cancer	7.05e-05	0.000783	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CXCL8—lung cancer	7.05e-05	0.000783	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AVP—lung cancer	7.03e-05	0.000781	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SDC4—lung cancer	6.9e-05	0.000766	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFC—lung cancer	6.83e-05	0.000758	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.72e-05	0.000746	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	6.59e-05	0.000731	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.5e-05	0.000722	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADCY1—lung cancer	6.45e-05	0.000716	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SMARCA4—lung cancer	6.28e-05	0.000698	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PPP2R1B—lung cancer	6.28e-05	0.000698	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—RRM1—lung cancer	6.28e-05	0.000698	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA3—lung cancer	6.28e-05	0.000698	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MDM2—lung cancer	6.13e-05	0.000681	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ATP5H—lung cancer	6.12e-05	0.00068	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—RAF1—lung cancer	6.11e-05	0.000678	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—POMC—lung cancer	6.1e-05	0.000678	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HSPB1—lung cancer	6.06e-05	0.000673	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTHLH—lung cancer	5.99e-05	0.000666	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—AVP—lung cancer	5.99e-05	0.000666	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—B4GALT5—lung cancer	5.91e-05	0.000656	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCB1—lung cancer	5.8e-05	0.000645	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA4—lung cancer	5.75e-05	0.000638	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ANXA1—lung cancer	5.64e-05	0.000626	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.63e-05	0.000625	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA2—lung cancer	5.6e-05	0.000622	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	5.57e-05	0.000619	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FLT1—lung cancer	5.46e-05	0.000606	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLBD1—lung cancer	5.46e-05	0.000606	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CG—lung cancer	5.41e-05	0.000601	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA1—lung cancer	5.4e-05	0.0006	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.37e-05	0.000596	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOTCH3—lung cancer	5.34e-05	0.000593	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APP—lung cancer	5.34e-05	0.000593	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCC3—lung cancer	5.34e-05	0.000593	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF9—lung cancer	5.3e-05	0.000589	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	5.22e-05	0.000579	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKR1C1—lung cancer	5.17e-05	0.000575	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—POMC—lung cancer	5.15e-05	0.000572	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JUNB—lung cancer	5.06e-05	0.000562	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—UGT1A1—lung cancer	5.02e-05	0.000558	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD17B10—lung cancer	4.99e-05	0.000554	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CG—lung cancer	4.91e-05	0.000545	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GNG11—lung cancer	4.84e-05	0.000538	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CD—lung cancer	4.75e-05	0.000528	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	4.72e-05	0.000524	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—POMC—lung cancer	4.67e-05	0.000519	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CKB—lung cancer	4.64e-05	0.000515	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALDOA—lung cancer	4.61e-05	0.000512	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STK11—lung cancer	4.59e-05	0.00051	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOA1—lung cancer	4.58e-05	0.000509	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6R—lung cancer	4.56e-05	0.000506	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NCOA3—lung cancer	4.48e-05	0.000497	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FOXO3—lung cancer	4.43e-05	0.000492	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—HRAS—lung cancer	4.39e-05	0.000487	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CNDP2—lung cancer	4.36e-05	0.000485	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM2—lung cancer	4.36e-05	0.000485	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ADCY1—lung cancer	4.36e-05	0.000484	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCG2—lung cancer	4.36e-05	0.000484	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAP2K1—lung cancer	4.35e-05	0.000483	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CD—lung cancer	4.32e-05	0.000479	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HPGDS—lung cancer	4.27e-05	0.000474	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ENO2—lung cancer	4.27e-05	0.000474	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTMR3—lung cancer	4.24e-05	0.000471	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPP2R1B—lung cancer	4.24e-05	0.000471	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AVP—lung cancer	4.16e-05	0.000461	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CB—lung cancer	4.14e-05	0.00046	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTT1—lung cancer	4.14e-05	0.00046	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PGAM1—lung cancer	4.14e-05	0.000459	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCLC—lung cancer	4.1e-05	0.000455	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2A6—lung cancer	4.1e-05	0.000455	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1R—lung cancer	4e-05	0.000444	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CXCL8—lung cancer	3.98e-05	0.000442	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2A7—lung cancer	3.95e-05	0.000438	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HES1—lung cancer	3.93e-05	0.000436	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ENO1—lung cancer	3.88e-05	0.000431	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	3.88e-05	0.000431	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SDC4—lung cancer	3.86e-05	0.000429	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—RAF1—lung cancer	3.85e-05	0.000428	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—IL2—lung cancer	3.81e-05	0.000423	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CB—lung cancer	3.76e-05	0.000418	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	3.63e-05	0.000403	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CXCL8—lung cancer	3.62e-05	0.000402	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB3—lung cancer	3.59e-05	0.000399	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—RRM1—lung cancer	3.52e-05	0.000391	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA3—lung cancer	3.52e-05	0.000391	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2E1—lung cancer	3.48e-05	0.000387	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL2—lung cancer	3.46e-05	0.000384	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TERT—lung cancer	3.44e-05	0.000382	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NQO1—lung cancer	3.44e-05	0.000382	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—HRAS—lung cancer	3.36e-05	0.000373	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGFR1—lung cancer	3.34e-05	0.000371	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—B4GALT5—lung cancer	3.31e-05	0.000367	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HIF1A—lung cancer	3.29e-05	0.000366	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	3.28e-05	0.000365	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA4—lung cancer	3.22e-05	0.000357	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA1—lung cancer	3.18e-05	0.000353	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KDR—lung cancer	3.15e-05	0.00035	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.14e-05	0.000349	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA2—lung cancer	3.13e-05	0.000348	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—STK11—lung cancer	3.1e-05	0.000345	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA1—lung cancer	3.02e-05	0.000336	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCC3—lung cancer	2.99e-05	0.000332	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CG—lung cancer	2.9e-05	0.000322	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KIT—lung cancer	2.9e-05	0.000322	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APC—lung cancer	2.9e-05	0.000322	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—NRAS—lung cancer	2.9e-05	0.000322	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKR1C1—lung cancer	2.9e-05	0.000322	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTP1—lung cancer	2.87e-05	0.000319	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGF—lung cancer	2.87e-05	0.000318	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—UGT1A1—lung cancer	2.81e-05	0.000312	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAT—lung cancer	2.79e-05	0.00031	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MAPK3—lung cancer	2.78e-05	0.000309	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—POMC—lung cancer	2.76e-05	0.000307	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BRAF—lung cancer	2.73e-05	0.000303	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCB1—lung cancer	2.72e-05	0.000302	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GNG11—lung cancer	2.71e-05	0.000301	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.7e-05	0.0003	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6R—lung cancer	2.69e-05	0.000299	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CREBBP—lung cancer	2.69e-05	0.000299	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TYMS—lung cancer	2.67e-05	0.000296	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EGFR—lung cancer	2.64e-05	0.000294	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—lung cancer	2.64e-05	0.000293	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALDOA—lung cancer	2.58e-05	0.000287	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAP2K1—lung cancer	2.57e-05	0.000285	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CD—lung cancer	2.55e-05	0.000283	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PIK3CA—lung cancer	2.53e-05	0.000281	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NCOA3—lung cancer	2.51e-05	0.000278	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP1A1—lung cancer	2.5e-05	0.000278	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—KRAS—lung cancer	2.5e-05	0.000277	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ERCC2—lung cancer	2.48e-05	0.000276	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.46e-05	0.000273	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCG2—lung cancer	2.44e-05	0.000271	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ADCY1—lung cancer	2.44e-05	0.000271	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ENO2—lung cancer	2.39e-05	0.000266	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HPGDS—lung cancer	2.39e-05	0.000266	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPP2R1B—lung cancer	2.38e-05	0.000264	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.34e-05	0.00026	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTT1—lung cancer	2.32e-05	0.000258	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PIK3CA—lung cancer	2.29e-05	0.000255	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCLC—lung cancer	2.29e-05	0.000255	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2A6—lung cancer	2.29e-05	0.000255	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MDM2—lung cancer	2.28e-05	0.000254	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.28e-05	0.000254	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RAF1—lung cancer	2.28e-05	0.000253	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ERBB2—lung cancer	2.25e-05	0.00025	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MTOR—lung cancer	2.22e-05	0.000247	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CB—lung cancer	2.22e-05	0.000247	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ENO1—lung cancer	2.17e-05	0.000241	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.16e-05	0.00024	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA1—lung cancer	2.15e-05	0.000238	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.14e-05	0.000237	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CXCL8—lung cancer	2.14e-05	0.000237	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HRAS—lung cancer	2.12e-05	0.000236	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—lung cancer	2.06e-05	0.000229	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—lung cancer	2.04e-05	0.000227	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL2—lung cancer	2.04e-05	0.000227	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—lung cancer	2.03e-05	0.000226	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCND1—lung cancer	1.99e-05	0.000221	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—JUN—lung cancer	1.99e-05	0.000221	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CG—lung cancer	1.96e-05	0.000218	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2E1—lung cancer	1.95e-05	0.000216	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—lung cancer	1.93e-05	0.000215	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NQO1—lung cancer	1.93e-05	0.000214	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1A—lung cancer	1.93e-05	0.000214	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTEN—lung cancer	1.92e-05	0.000213	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.89e-05	0.00021	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—lung cancer	1.87e-05	0.000208	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.87e-05	0.000208	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—POMC—lung cancer	1.87e-05	0.000207	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EP300—lung cancer	1.83e-05	0.000203	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CREBBP—lung cancer	1.82e-05	0.000202	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SRC—lung cancer	1.78e-05	0.000198	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—STK11—lung cancer	1.74e-05	0.000193	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—lung cancer	1.73e-05	0.000193	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CD—lung cancer	1.72e-05	0.000191	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—STAT3—lung cancer	1.72e-05	0.000191	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NRAS—lung cancer	1.71e-05	0.00019	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—lung cancer	1.7e-05	0.000189	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK3—lung cancer	1.64e-05	0.000182	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.63e-05	0.000181	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTP1—lung cancer	1.61e-05	0.000179	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MYC—lung cancer	1.6e-05	0.000177	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAT—lung cancer	1.56e-05	0.000174	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EGFR—lung cancer	1.56e-05	0.000173	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.56e-05	0.000173	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCB1—lung cancer	1.52e-05	0.000169	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CB—lung cancer	1.5e-05	0.000167	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TYMS—lung cancer	1.49e-05	0.000166	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—lung cancer	1.49e-05	0.000165	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—lung cancer	1.48e-05	0.000164	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—KRAS—lung cancer	1.47e-05	0.000164	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP1A1—lung cancer	1.4e-05	0.000156	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ERCC2—lung cancer	1.39e-05	0.000154	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PIK3CA—lung cancer	1.36e-05	0.00015	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—lung cancer	1.31e-05	0.000146	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTEN—lung cancer	1.3e-05	0.000144	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HRAS—lung cancer	1.25e-05	0.000139	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—EP300—lung cancer	1.24e-05	0.000137	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA1—lung cancer	1.2e-05	0.000133	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—lung cancer	1.2e-05	0.000133	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.15e-05	0.000128	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—lung cancer	1.11e-05	0.000123	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CG—lung cancer	1.1e-05	0.000122	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—POMC—lung cancer	1.04e-05	0.000116	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CREBBP—lung cancer	1.02e-05	0.000113	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CD—lung cancer	9.64e-06	0.000107	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—lung cancer	9.52e-06	0.000106	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PIK3CA—lung cancer	9.15e-06	0.000102	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CB—lung cancer	8.4e-06	9.33e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—lung cancer	8.33e-06	9.25e-05	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—lung cancer	7.48e-06	8.3e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTEN—lung cancer	7.26e-06	8.06e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—EP300—lung cancer	6.93e-06	7.69e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PIK3CA—lung cancer	5.12e-06	5.69e-05	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—lung cancer	4.18e-06	4.65e-05	CbGpPWpGaD
